BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 35696536)

  • 1.
    Shi L; Chen B; Liu T; Li L; Hu B; Li C; Jia B; Wang F
    Mol Pharm; 2022 Jul; 19(7):2583-2594. PubMed ID: 35696536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical Development of Near-Infrared-Labeled CD38-Targeted Daratumumab for Optical Imaging of CD38 in Multiple Myeloma.
    Cho N; Ko S; Shokeen M
    Mol Imaging Biol; 2021 Apr; 23(2):186-195. PubMed ID: 32964391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging of Integrin α
    Song YS; Park HS; Lee BC; Jung JH; Lee HY; Kim SE
    Cancer Biother Radiopharm; 2017 Oct; 32(8):288-296. PubMed ID: 29053416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical evaluation of [
    Liu T; Wu Y; Shi L; Li L; Hu B; Wang Y; Gao H; Yu X; Zhang X; Zhao H; Wan Y; Jia B; Wang F
    Eur J Nucl Med Mol Imaging; 2022 May; 49(6):1810-1821. PubMed ID: 35013776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular imaging of HER2 expression in breast cancer patients using a novel peptide-based tracer
    Shi J; Du S; Wang R; Gao H; Luo Q; Hou G; Zhou Y; Zhu Z; Wang F
    J Transl Med; 2023 Jan; 21(1):19. PubMed ID: 36631812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and Preliminary Study of
    Ma M; Yang G; Zhao M; Liu Y; Ge X; Jia B; Gao S
    Mol Pharm; 2024 Feb; 21(2):735-744. PubMed ID: 38193393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of HER2 expression using
    Zhao L; Xing Y; Liu C; Ma S; Huang W; Cheng Z; Zhao J
    Breast Cancer Res; 2024 Mar; 26(1):40. PubMed ID: 38459598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrin α(v)β₃-targeted radiotracer (99m)Tc-3P-RGD₂ useful for noninvasive monitoring of breast tumor response to antiangiogenic linifanib therapy but not anti-integrin α(v)β₃ RGD₂ therapy.
    Ji S; Zheng Y; Shao G; Zhou Y; Liu S
    Theranostics; 2013; 3(11):816-30. PubMed ID: 24312152
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Kang L; Li C; Yang Q; Sutherlin L; Wang L; Chen Z; Becker KV; Huo N; Qiu Y; Engle JW; Wang R; He C; Jiang D; Xu X; Cai W
    Eur J Nucl Med Mol Imaging; 2022 Apr; 49(5):1470-1481. PubMed ID: 34677626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroSPECT/CT Imaging of Cell-Line and Patient-Derived EGFR-Positive Tumor Xenografts in Mice with Panitumumab Fab Modified with Hexahistidine Peptides To Enable Labeling with
    Ku A; Chan C; Aghevlian S; Cai Z; Cescon D; Bratman SV; Ailles L; Hedley DW; Reilly RM
    Mol Pharm; 2019 Aug; 16(8):3559-3568. PubMed ID: 31242384
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Elvas F; Boddaert J; Vangestel C; Pak K; Gray B; Kumar-Singh S; Staelens S; Stroobants S; Wyffels L
    J Nucl Med; 2017 Apr; 58(4):665-670. PubMed ID: 27879368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 99mTc-labeled RGD-BBN peptide for small-animal SPECT/CT of lung carcinoma.
    Liu Z; Huang J; Dong C; Cui L; Jin X; Jia B; Zhu Z; Li F; Wang F
    Mol Pharm; 2012 May; 9(5):1409-17. PubMed ID: 22452411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 99mTc-labeled cystine knot peptide targeting integrin αvβ6 for tumor SPECT imaging.
    Zhu X; Li J; Hong Y; Kimura RH; Ma X; Liu H; Qin C; Hu X; Hayes TR; Benny P; Gambhir SS; Cheng Z
    Mol Pharm; 2014 Apr; 11(4):1208-17. PubMed ID: 24524409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the biodistribution and tumor targeting of two 99mTc-labeled anti-EGFR nanobodies in mice, using pinhole SPECT/micro-CT.
    Gainkam LO; Huang L; Caveliers V; Keyaerts M; Hernot S; Vaneycken I; Vanhove C; Revets H; De Baetselier P; Lahoutte T
    J Nucl Med; 2008 May; 49(5):788-95. PubMed ID: 18413403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noninvasive Evaluation of Tumoral PD-L1 Using a Novel
    Hu B; Ma X; Shi L; Liu T; Li L; Yao M; Li C; Jia B
    Mol Pharm; 2024 Apr; 21(4):1977-1986. PubMed ID: 38395797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A brief evaluation of tumor imaging in mice with 99mTc-glucarate including a comparison with 18F-FDG.
    Cheng D; Rusckowski M; Wang Y; Liu Y; Liu G; Liu X; Hnatowich D
    Curr Radiopharm; 2011 Jan; 4(1):5-9. PubMed ID: 22191610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigations of (99m)Tc-labeled glucarate as a SPECT radiotracer for non-small cell lung cancer (NSCLC) and potential tumor uptake mechanism.
    Meng L; Xiu Y; Li Y; Xu X; Li S; Li X; Pak KY; Shi H; Cheng D
    Nucl Med Biol; 2015 Jul; 42(7):608-13. PubMed ID: 25890861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 99mTc-labeled estradiol as an estrogen receptor probe: Preparation and preclinical evaluation.
    Xia X; Feng H; Li C; Qin C; Song Y; Zhang Y; Lan X
    Nucl Med Biol; 2016 Jan; 43(1):89-96. PubMed ID: 26466867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of (99m)Tc-HYNIC-TMTP1 as a tumor-homing imaging agent targeting metastasis with SPECT.
    Li F; Cheng T; Dong Q; Wei R; Zhang Z; Luo D; Ma X; Wang S; Gao Q; Ma D; Zhu X; Xi L
    Nucl Med Biol; 2015 Mar; 42(3):256-62. PubMed ID: 25516099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.